The DEA did not ban shipping of hemp-derived CBD products
Rumors abound about a DEA policy shift on Hemp-Derived CBD.
The Drug Enforcement Agency published a bulletin (on 12/14) regarding a new drug classification for marijuana extracts. Effectively, they created a category for all manufactured extracts produced through any type of processing, in order to better classify and track marijuana concentrates. The rule posted on the Federal Register’s website states:
“The Drug Enforcement Administration is creating a new Administration Controlled Substances Code Number for ‘Marihuana Extract.’ This code number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana.”
The announcement of this rule publication immediately set off rumors across the internet, primarily sourced to an article in the Huffington Post’s Contributors’ section. It suggested the Drug Enforcement Agency had launched a new offensive by reclassifying CBD, and the Federal ruling would prevent the shipment of CBD products across the US. Feeding into conspiracy, the article noted the spelling of “marihuana” in the Federal Register as a way for the DEA to somehow create new rules of engagement without being noticed during internet searches conducted on the terms “DEA marijuana”. The article has now been removed from the Huffington Post’s website.